A detailed history of Charter Research & Investment Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Charter Research & Investment Group, Inc. holds 34,713 shares of MRK stock, worth $3.38 Million. This represents 2.91% of its overall portfolio holdings.

Number of Shares
34,713
Previous 34,938 0.64%
Holding current value
$3.38 Million
Previous $4.33 Million 8.86%
% of portfolio
2.91%
Previous 3.41%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $25,008 - $29,018
-225 Reduced 0.64%
34,713 $3.94 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $57,690 - $61,959
-466 Reduced 1.32%
34,938 $4.33 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $56,846 - $66,238
502 Added 1.44%
35,404 $4.67 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $45,298 - $50,305
-440 Reduced 1.24%
34,902 $3.59 Million
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $24,437 - $26,635
-225 Reduced 0.63%
35,342 $4.08 Million
Q1 2023

May 08, 2023

BUY
$102.94 - $114.86 $3,088 - $3,445
30 Added 0.08%
35,567 $3.78 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $3,497 - $4,484
-40 Reduced 0.11%
35,537 $3.94 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $102,281 - $114,901
-1,210 Reduced 3.29%
35,577 $3.06 Million
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $3,339 - $3,785
-40 Reduced 0.11%
36,787 $3.35 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $69,099 - $77,456
-940 Reduced 2.49%
36,827 $3.02 Million
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $3,614 - $4,527
50 Added 0.13%
37,767 $2.89 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $14,336 - $15,766
200 Added 0.53%
37,717 $2.83 Million
Q2 2021

Aug 10, 2021

SELL
$70.31 - $77.77 $44,506 - $49,228
-633 Reduced 1.66%
37,517 $2.92 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $22,379 - $26,360
325 Added 0.86%
38,150 $2.94 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $16,865 - $18,717
235 Added 0.63%
37,825 $3.09 Million
Q3 2020

Nov 10, 2020

SELL
$73.18 - $82.95 $85,620 - $97,051
-1,170 Reduced 3.02%
37,590 $3.12 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $68,659 - $78,126
975 Added 2.58%
38,760 $3 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $9,504 - $13,172
150 Added 0.4%
37,785 $2.91 Million
Q4 2019

Jan 30, 2020

SELL
$77.58 - $87.54 $1,474 - $1,663
-19 Reduced 0.05%
37,635 $3.42 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $78,742 - $85,832
1,035 Added 2.83%
37,654 $3.17 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $55,173 - $64,456
-790 Reduced 2.11%
36,619 $3.07 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $20,874 - $23,808
-300 Reduced 0.8%
37,409 $3.11 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $58,063 - $67,381
-890 Reduced 2.31%
37,709 $2.88 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $23,076 - $27,136
-400 Reduced 1.03%
38,599 $2.74 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $16,256 - $18,894
319 Added 0.82%
38,999 $2.12 Million
Q4 2017

Feb 02, 2018

BUY
$51.62 - $61.64 $2 Million - $2.38 Million
38,680
38,680 $2.18 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Charter Research & Investment Group, Inc. Portfolio

Follow Charter Research & Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charter Research & Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Charter Research & Investment Group, Inc. with notifications on news.